CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback